MI/25/24 – Amit Patel Leukaemia Research Fellowship & Cancer Research UK Manchester Institute Senior Clinical Institute Fellow

Key Details

Job ID:
MI/25/24
Role:
Amit Patel Leukaemia Research Fellowship & Cancer Research UK Manchester Institute Senior Clinical Institute Fellow
Salary:
NHS Medical & Dental Consultant pay scale: £105,504 to £139,882 per annum (dependent upon experience)
Closing date:
18th May 2025

About the role

A fixed term 3-year appointment to develop an independent, high impact academic research programme with strong clinical translational potential aligned with the strategic goals of Cancer Research UK, the Cancer Research UK Manchester Institute and The Christie NHS Foundation Trust.

This is a new, full-time post (10 programmed activities (PAs)) per week with the CRUK Manchester Institute and The University of Manchester acting as the main employer and funding 8 PAs of research activity and The Christie NHS Foundation Trust providing an honorary consultant contract for 2 PAs of clinical activity in the clinical Department of Haematology.

A DBS Check will be required for this role.

About you

You should have blood cancer research interests aligned with those of the Cancer Research UK Manchester Institute and The Christie NHS Foundation Trust.

You will have: MRCP & FRCPath (or equivalent); a certificate of completion of specialist training in Haematology (or equivalent); full General Medical Council (GMC) registration with license to practice medicine in the UK; a PhD in a discipline relevant to blood cancer research along with a strong track record of published laboratory-based translational blood cancer research at doctoral and postdoctoral level.

Laboratory at Cancer Research UK Manchester Institute
Paterson Building Scientific Administration

More information

Informal enquiries

For any informal enquiries about this post, please contact Professor Tim Somervaille: tim.somervaille@cruk.manchester.ac.uk or Dr Faye Sharpley (Clinical Director): faye.sharpley@nhs.net or use the form below

How to apply

To apply for this position please complete the online Application which is by CV accompanied by a three page research proposal which outlines your ambitious future translational blood cancer research programme. Please ensure you detail the names of three referees and ensure you submit your application before the closing date specified.

Please note this vacancy will close for applications at 11:59pm on the closing date specified.

About CRUK Manchester Institute

The Cancer Research UK Manchester Institute is a Research Institute within The University of Manchester and is core funded by Cancer Research UK the largest independent cancer research organisation in the world.

In spring 2023 the Institute moved into the new Paterson Building, a £150 million flagship purpose-built biomedical research centre directly attached to The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials.

The Institute has access to outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.

Informal enquiries
How to apply
About CRUK Manchester Institute

How to apply

To apply for this position please complete the online Application on our secure portal, which is by CV accompanied by a three page research proposal which outlines your ambitious future translational blood cancer research programme.

Please ensure you detail the names of three referees and ensure you submit your application before the closing date specified.

Please note this vacancy will close for applications at 11:59pm on the closing date specified.

For any informal enquiries about this post, please use this form to contact Professor Tim Somervaille and Dr Faye Sharpley (Clinical Director)

Please enable JavaScript in your browser to complete this form.
Enter your full name
Enter your email address
Type your question here

Why choose Cancer Research UK Manchester Institute?

The Cancer Research UK Manchester Institute, an Institute of The University of Manchester, is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org),
the largest independent cancer research organisation in the world.

We are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe, which is located adjacent to the CRUK MI Manchester Institute in South Manchester. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Careers that have a lasting impact on cancer research and patient care

We are always on the lookout for talented and motivated people to join us.  Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.

Gloved hands filling a stripette white lab coat

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Leukaemia Immunology & Transplantation

The Leukaemia Immunology and Transplantation laboratory aim to develop a comprehensive strategy to prevent post-transplant relapse in patients treated with allogeneic haematopoietic stem cell transplantation – the only curative therapy for many patients with acute myeloid leukaemia (AML) and other poor-risk haematological malignancies.

Patient derived preclinical models reveal novel biology of SCLC

Immune detection of dying tumour cells can elicit cancer immunity when the host permits it

Cancer Research In the Paterson Building
Leukaemia Immunology & Transplantation
Patient derived preclinical models reveal novel biology of SCLC